Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update on the treatment of narcolepsy: clinical efficacy of pitolisant
Michael W. Calik
Nature and Science of Sleep (2017) Vol. Volume 9, pp. 127-133
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study
Yves Dauvilliers, Isabelle Arnulf, Zoltán Szakács, et al.
SLEEP (2019) Vol. 42, Iss. 11
Open Access | Times Cited: 230
Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy
Beatrice Setnik, Michael McDonnell, Catherine Mills, et al.
SLEEP (2019) Vol. 43, Iss. 4
Open Access | Times Cited: 183
Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications
Michael J. Thorpy, Richard Bogan
Sleep Medicine (2019) Vol. 68, pp. 97-109
Closed Access | Times Cited: 64
Histamine H3 receptor antagonists/inverse agonists: Where do they go?
Nakisa Ghamari, Omid Zarei, José‐Antonio Arias‐Montaño, et al.
Pharmacology & Therapeutics (2019) Vol. 200, pp. 69-84
Closed Access | Times Cited: 60
Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents
Anirban Ghoshal, Ajeet Kumar, D. Yugandhar, et al.
European Journal of Medicinal Chemistry (2018) Vol. 152, pp. 148-159
Closed Access | Times Cited: 54
Health-Related Quality of Life in Patients With Narcolepsy
Alberto Raggi, Giuseppe Plazzi, Raffaele Ferri
The Journal of Nervous and Mental Disease (2019) Vol. 207, Iss. 2, pp. 84-99
Closed Access | Times Cited: 41
<p>Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns</p>
Emily C. Barker, Julie Flygare, Shalini Paruthi, et al.
Nature and Science of Sleep (2020) Vol. Volume 12, pp. 453-466
Open Access | Times Cited: 35
Neural circuitry underlying REM sleep: A review of the literature and current concepts
Yi‐Qun Wang, Wenying Liu, Lei Li, et al.
Progress in Neurobiology (2021) Vol. 204, pp. 102106-102106
Closed Access | Times Cited: 25
Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017)
Dorota Łażewska, Katarzyna Kieć‐Kononowicz
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 3, pp. 175-196
Closed Access | Times Cited: 29
Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H3 receptor antagonists
Darren Riddy, Anna E. Cook, David M. Shackleford, et al.
Neuropharmacology (2018) Vol. 144, pp. 244-255
Open Access | Times Cited: 27
Cataplexy
Paul Reading
Practical Neurology (2018) Vol. 19, Iss. 1, pp. 21-27
Closed Access | Times Cited: 27
Narcolepsy: an interface among neurology, immunology, sleep, and genetics
Fernando Morgadinho Santos Coelho
Arquivos de Neuro-Psiquiatria (2024) Vol. 82, Iss. 06, pp. 001-009
Open Access | Times Cited: 2
Pitolisant for treating patients with narcolepsy
Shuang Li, Junyi Yang
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 2, pp. 79-84
Closed Access | Times Cited: 16
Update on narcolepsy
Paul Reading
Journal of Neurology (2019) Vol. 266, Iss. 7, pp. 1809-1815
Closed Access | Times Cited: 17
Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy
Junyi Yang, Junfa Gao
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 8, pp. 723-728
Closed Access | Times Cited: 15
Article Commentary: Pharmacokinetic and Pharmacodynamic of the Cognitive Enhancer Modafinil: Relevant Clinical and Forensic Aspects
Ana Catarina Sousa, Ricardo Jorge Dinis‐Oliveira
Substance Abuse (2020) Vol. 41, Iss. 2, pp. 155-173
Closed Access | Times Cited: 14
Optimal dose determination of enerisant (TS-091) for patients with narcolepsy: two randomized, double-blind, placebo-controlled trials
Yuichi Inoue, Makoto Uchiyama, Hideo Umeuchi, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Pitolisant and intravenous cocaine self-administration in mice
Benjamin Huyts, Christian Brabant, Ezio Tirelli
European Journal of Pharmacology (2019) Vol. 851, pp. 63-68
Closed Access | Times Cited: 12
The cost utility of pitolisant as narcolepsy treatment
Kristian Bolin, Per‐Åke Niska, Laura Pirhonen, et al.
Acta Neurologica Scandinavica (2019) Vol. 141, Iss. 4, pp. 301-310
Closed Access | Times Cited: 12
Pharmacological interventions for the treatment of obstructive sleep apnea syndrome
Jin Liu, Xiaolan Yang, Guangcai Li, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Phenoxyalkyl cyclic and acyclic amine derivatives: what do they teach us about scaffold-based drug design?
Mohammad Mahdi Rezaeifar, Ardavan Abiri, Hojjat Rezaiezadeh, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 5, pp. 703-720
Closed Access | Times Cited: 1
Pitolisant in an Adolescent with Prader-Willi Syndrome
Stephanie Pennington, Danielle L. Stutzman, Elise M. Sannar
The Journal of Pediatric Pharmacology and Therapeutics (2021) Vol. 26, Iss. 4, pp. 405-410
Open Access | Times Cited: 10
Nitric oxide mediates the antidepressant-like effect of modafinil in mouse forced swimming and tail suspension tests
Hossein Omidi-Ardali, Abolfazl Ghasemi Badi, Elham Saghaei, et al.
Journal of Basic and Clinical Physiology and Pharmacology (2020) Vol. 32, Iss. 2, pp. 25-31
Closed Access | Times Cited: 9
Therapeutic Potential of Histamine H3 Receptors in Substance Use Disorders
Patricia Di Ciano, Christian S. Hendershot, Bernard Le Foll
Current topics in behavioral neurosciences (2022), pp. 169-191
Closed Access | Times Cited: 5
Drugs for patients with epilepsy and excessive daytime sleepiness
Gaetano Zaccara, Emanuele Bartolini, Luciana Tramacere, et al.
Epilepsy & Behavior (2021) Vol. 124, pp. 108311-108311
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top